References
- TorreLATrabertBDeSantisCEOvarian cancer statistics, 2018CA Cancer J Clin201868428429629809280
- VergoteITropéCGAmantFEuropean Organization for Research and Treatment of Cancer-Gynaecological Cancer Group; NCIC Clinical Trials GroupNeoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancerN Engl J Med20103631094395320818904
- MacciòAMadedduCInflammation and ovarian cancerCytokine201258213314722349527
- DupréAMalikHZInflammation and cancer: what a surgical oncologist should knowEur J Surg Oncol201844556657029530345
- ZhangWYeBLiangWRenYPreoperative prognostic nutritional index is a powerful predictor of prognosis in patients with stage III ovarian cancerSci Rep201771954828842710
- ZhuJYLiuCCWangLZhongMTangHLWangHPeripheral blood lymphocyte-to-monocyte ratio as a prognostic factor in advanced epithelial ovarian cancer: a multicenter retrospective studyJ Cancer20178573774328382135
- EoWKChangHJKwonSHThe lymphocyte-monocyte ratio predicts patient survival and aggressiveness of ovarian cancerJ Cancer20167328929626918042
- KwonBSJeongDHByunJMPrognostic value of preoperative lymphocyte-monocyte ratio in patients with ovarian clear cell carcinomaJ Cancer2018971127113429675093
- KwonBSLeeHJYangJSongYJSuhDSLeeDHKimKHPrognostic value of preoperative lymphocyte-monocyte ratio in elderly patients with advanced epithelial ovarian cancerObstet Gynecol Sci201760655856429184864
- LiZHongNRobertsonMWangCJiangGPreoperative red cell distribution width and neutrophil-to-lymphocyte ratio predict survival in patients with epithelial ovarian cancerSci Rep201774300128223716
- XiangJZhouLLiXPreoperative monocyte-to-lymphocyte ratio in peripheral blood predicts stages, metastasis, and histological grades in patients with ovarian cancerTransl Oncol2017101333927888711
- MoherDLiberatiATetzlaffJAltmanDGPRISMA GroupPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementPLoS Med200967e100009719621072
- ParmarMKTorriVStewartLExtracting summary statistics to perform meta-analyses of the published literature for survival endpointsStat Med19981724281528349921604
- StangACritical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEur J Epidemiol201025960360520652370
- HamlingJLeePWeitkunatRAmbühlMFacilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease categoryStat Med200827795497017676579
- RileyRDHigginsJPDeeksJJInterpretation of random effects meta-analysesBMJ2011342d54921310794
- HigginsJPThompsonSGQuantifying heterogeneity in a meta-analysisStat Med200221111539155812111919
- ManderAClaytonDAssessing the influence of a single study in meta-analysisStata Tech Bull19998108110
- WangXThe Relationship Between Preoperative Blood Lymphocyte-To-Monocyte Ratio and the Prognostic of Epithelial Ovarian CancerZheng Zhou, ChinaThe First Affiliated Hospital of Zheng Zhou University2017
- RomitoAMarchettiCdi SantoGMonocyte-to-lymphocyte ratio as predictor of survival and response to treatment in ovarian cancerInt J Gynecol Cancer1913201727
- SunLSongYEffects of lymphocyte and monocyte ratio on prognosis of epithelial ovarian cancerChinese Clin Oncol201610909912
- TangYLiJXuFHuHAssociation between monocyte-to-lymphocyte ratio and prognosis of patients with epithelial ovarian cancerAm J Obstet Gynecol Pediat20175532538
- TianYAnalysis of Prognostic Factors of Epithelial Ovarian CancerHe Bei, ChinaHebei Medical University2017
- WangXYuanZQiuHThe relationship between preoperative blood lymphocyte-to-monocyte ratio and the prognostic of epithelial ovarian cancerProg Obstet Gynecol20169654657
- YangHMLouGThe relationship of preoperative lymphocyte-monocyte ratio and the clinicopathological characteristics and prognosis of patients with epithelial ovarian cancerZhonghua Zhong Liu Za Zhi201739967668028926896
- ThamTOlsonCKhaymovichJHermanSWCostantinoPDThe lymphocyte-to-monocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysisEur Arch Otorhinolaryngol201827571663167029651542
- HuRJMaJYHuGLymphocyte-to-monocyte ratio in pancreatic cancer: prognostic significance and meta-analysisClin Chim Acta201848114214629544747
- SongWWangKZhangRJZouSBPrognostic value of the lymphocyte monocyte ratio in patients with colorectal cancer: a meta-analysisMedicine (Baltimore)20169549e554027930549
- SongWTianCWangKZhangRJZouSBThe pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with hepatocellular carcinoma: a meta-analysisSci Rep201774660128417972
- HuRJLiuQMaJYZhouJLiuGPreoperative lymphocyte-to-monocyte ratio predicts breast cancer outcome: a meta-analysisClin Chim Acta20184841629775617
- ZhuYLiMBoCPrognostic significance of the lymphocyte-to-monocyte ratio and the tumor-infiltrating lymphocyte to tumor-associated macrophage ratio in patients with stage T3N0M0 esophageal squamous cell carcinomaCancer Immunol Immunother201766334335427915370
- BalkwillFMantovaniAInflammation and cancer: back to Virchow?Lancet2001357925553954511229684
- SatoEOlsonSHAhnJIntraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancerProc Natl Acad Sci U S A200510251185381854316344461
- SatoEOlsonSHAhnJIntraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancerProc Natl Acad Sci U S A200510251185381854316344461
- ZhangLConejo-GarciaJRKatsarosDIntratumoral T cells, recurrence, and survival in epithelial ovarian cancerN Engl J Med2003348320321312529460
- HwangWTAdamsSFTahirovicEHagemannISCoukosGPrognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysisGynecol Oncol2012124219219822040834
- LeeKHKimEYYunJSParkYLDoSIChaeSWParkCHThe prognostic and predictive value of tumor-infiltrating lymphocytes and hematologic parameters in patients with breast cancerBMC Cancer201818193830285668
- CondeelisJPollardJWMacrophages: obligate partners for tumor cell migration, invasion, and metastasisCell2006124226326616439202
- CoussensLMWerbZInflammation and cancerNature2002420691786086712490959
- McCloskeyCWRodriguezGMGalpinKJCVanderhydenBCOvarian cancer immunotherapy: preclinical models and emerging therapeuticsCancers (Basel)2018108E24430049987
- SekineKKandaSGotoYChange in the lymphocyte-to-monocyte ratio is an early surrogate marker of the efficacy of nivolumab monotherapy in advanced non-small-cell lung cancerLung Cancer201812417918830268458
- ElisiaILamVHofsEEffect of age on chronic inflammation and responsiveness to bacterial and viral challengesPLoS One20171211e018888129186188
- KugelCHDouglassSMWebsterMRAge correlates with response to anti-PD1, reflecting age-related differences in intratumoral effector and regulatory T-cell populationsClin Cancer Res201824215347535629898988
- EliasRGiobbie-HurderAMcClearyNJOttPHodiFSRahmaOEfficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysisJ Immunother Cancer2018612629618381